Literature DB >> 22514302

Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo.

David L Schonberg1, Evan Z Goldstein, Fatma Rezan Sahinkaya, Ping Wei, Phillip G Popovich, Dana M McTigue.   

Abstract

Injured CNS tissue often contains elevated iron and its storage protein ferritin, which may exacerbate tissue damage through pro-oxidative mechanisms. Therefore, therapeutic studies often target iron reduction as a neuroprotective strategy. However, iron may be crucial for oligodendrocyte replacement and remyelination. For instance, we previously showed that intraspinal toll-like receptor 4 macrophage activation induced the generation of new ferritin-positive oligodendrocytes, and that iron chelation significantly reduced this oligodendrogenic response. Since macrophages can secrete ferritin, we hypothesize that ferritin is a macrophage-derived signal that promotes oligodendrogenesis. To test this, we microinjected ferritin into intact adult rat spinal cords. Within 6 h, NG2+ progenitor cells proliferated and accumulated ferritin. By 3 d, many of these cells had differentiated into new oligodendrocytes. However, acute neuron and oligodendrocyte toxicity occurred in gray matter. Interestingly, ferritin-positive NG2 cells and macrophages accumulated in the area of cell loss, revealing that NG2 cells thrive in an environment that is toxic to other CNS cells. To test whether ferritin can be transferred from macrophages to NG2 cells in vivo, we loaded macrophages with fluorescent ferritin then transplanted them into intact spinal white matter. Within 3-6 d, proliferating NG2 cells migrated into the macrophage transplants and accumulated fluorescently labeled ferritin. These results show that activated macrophages can be an in vivo source of ferritin for NG2 cells, which induces their proliferation and differentiation into new oligodendrocytes. This work has relevance for conditions in which iron-mediated injury and/or repair likely occur, such as hemorrhage, stroke, spinal cord injury, aging, Parkinson's disease, and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514302      PMCID: PMC3521599          DOI: 10.1523/JNEUROSCI.3517-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis.

Authors:  S W Hulet; S O Heyliger; S Powers; J R Connor
Journal:  J Neurosci Res       Date:  2000-07-01       Impact factor: 4.164

2.  Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination.

Authors:  J L Mason; J J Jones; M Taniike; P Morell; K Suzuki; G K Matsushima
Journal:  J Neurosci Res       Date:  2000-08-01       Impact factor: 4.164

3.  Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

Authors:  José M Vela; Eduardo Molina-Holgado; Angel Arévalo-Martín; Guillermina Almazán; Carmen Guaza
Journal:  Mol Cell Neurosci       Date:  2002-07       Impact factor: 4.314

4.  Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury.

Authors:  K D Dougherty; C F Dreyfus; I B Black
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

5.  Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor.

Authors:  L M Herx; S Rivest; V W Yong
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

6.  Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes.

Authors:  D J Morath; M Mayer-Pröschel
Journal:  Dev Biol       Date:  2001-09-01       Impact factor: 3.582

7.  Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron.

Authors:  O Alcantara; M Kalidas; I Baltathakis; D H Boldt
Journal:  Exp Hematol       Date:  2001-09       Impact factor: 3.084

8.  Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.

Authors:  T Simonart; C Degraef; G Andrei; R Mosselmans; P Hermans; J P Van Vooren; J C Noel; J R Boelaert; R Snoeck; M Heenen
Journal:  J Invest Dermatol       Date:  2000-11       Impact factor: 8.551

Review 9.  Brain iron pathways and their relevance to Parkinson's disease.

Authors:  D Berg; M Gerlach; M B Youdim; K L Double; L Zecca; P Riederer; G Becker
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

10.  The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes.

Authors:  Geraldine J Kress; Kirk E Dineley; Ian J Reynolds
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

View more
  43 in total

1.  Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease.

Authors:  Sara van Duijn; Rob J A Nabuurs; Sjoerd G van Duinen; Remco Natté
Journal:  J Histochem Cytochem       Date:  2013-07-25       Impact factor: 2.479

2.  Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.

Authors:  Martina Absinta; Pascal Sati; Matthew Schindler; Emily C Leibovitch; Joan Ohayon; Tianxia Wu; Alessandro Meani; Massimo Filippi; Steven Jacobson; Irene C M Cortese; Daniel S Reich
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

3.  TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.

Authors:  Jamie S Church; Kristina A Kigerl; Jessica K Lerch; Phillip G Popovich; Dana M McTigue
Journal:  J Neurosci       Date:  2016-06-08       Impact factor: 6.167

Review 4.  The benefits of neuroinflammation for the repair of the injured central nervous system.

Authors:  Heather Y F Yong; Khalil S Rawji; Samira Ghorbani; Mengzhou Xue; V Wee Yong
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 5.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

6.  Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage.

Authors:  F Rezan Sahinkaya; Lindsay M Milich; Dana M McTigue
Journal:  Exp Neurol       Date:  2014-03-11       Impact factor: 5.330

Review 7.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

Review 8.  Differential Modulators of NG2-Glia Differentiation into Neurons and Glia and Their Crosstalk.

Authors:  Xiaohuang Du; Zuo Zhang; Hongli Zhou; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2020-04-13       Impact factor: 5.046

9.  Impaired Postnatal Myelination in a Conditional Knockout Mouse for the Ferritin Heavy Chain in Oligodendroglial Cells.

Authors:  Rensheng Wan; Veronica T Cheli; Diara A Santiago-González; Shaina L Rosenblum; Qiuchen Wan; Pablo M Paez
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

10.  Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage.

Authors:  Evan Z Goldstein; Jamie S Church; Nicole Pukos; Manoj K Gottipati; Phillip G Popovich; Dana M McTigue
Journal:  Exp Neurol       Date:  2017-08-26       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.